Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
14.10
-0.39 (-2.69%)
At close: Jun 27, 2025, 4:00 PM
14.00
-0.10 (-0.71%)
After-hours: Jun 27, 2025, 6:14 PM EDT

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $2.05 billion as of June 27, 2025. Its market cap has decreased by -31.67% in one year.

Market Cap
2.05B
Enterprise Value
1.05B
1-Year Change
-31.67%
Ranking
Category
Stock Price
$14.10

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.05B, an increase of 8.54%. That is a compound annual growth rate of 1.09%.

History

DateMarket Cap% Change
Jun 26, 20252.11B-28.23%
Dec 31, 20242.93B-1.10%
Dec 29, 20232.97B-21.48%
Dec 30, 20223.78B-30.66%
Dec 31, 20215.45B-45.77%
Dec 31, 202010.04B500.43%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 713.81B
Johnson & Johnson 365.75B
AbbVie 329.95B
Novo Nordisk 299.93B
UnitedHealth Group 274.52B
Novartis AG 235.02B
Abbott Laboratories 232.56B
AstraZeneca 215.99B
Market Cap Rankings